Keynote Address: Laurent Audoly, Head, Research & Development, Pierre Fabre Pharmaceuticals

Panel A

Dario Guitierrez, Immuno-biology Lead, Merck Research Labs Cambridge Exploratory Science Center

Amy Halseth, Vice President, Clinical Development and Medical Affairs, Orexigen Therapeutics

Janina Jeff, Global Bioinformatician, Illumina

Panel B

Diane Kanter, Scientific Content Liaison, Education and Training Systems

Cyrus Martin, Senior Scientific Editor, Current Biology

Tara Ruest Gower, Vice-President, Scientific Services, Scientific Pathways

Panel C

Meredith Brown, Senior Manager, Intellectual Property, Metabolon

​Kim Lickteig, Associate Director, Global Regulatory Affairs, Takeda

Lori Rudolph-Owen, Vice President, Portfolio Management and Assessment, TESARO, Inc

Ray Price, Vice President, Business Development, DiscoverX Corp

Panel D

Mark Hansberger, Senior Intelligence Specialist, Defense Threat Reduction Agency

Kristin Herring, Health Scientist, Biomedical Advanced Research and Development Authority (BARDA) Division of Chemical Biological Radiological Nuclear (CBRN) Countermeasures

John Lowe, Patent Officer, United States Patent and Trademark Office

Featured Half Hour​​ Lunch Speakers

Victor Torres, Associate Professor, Department of Microbiology and Immunology and Inflammation Graduate Training Programs, New York University School of Medicine

Erin Henry, Medical Science Director/Medical Team Leader, US Medical Affairs, Genentech

Networking Huddles (small group opportunity to meet with speakers and additional invited alumni)

Networking Reception

As part of the BRET Reunion activities, alumni are invited to attend the Networking Reception (held in the Board of Trust Room) to meet and greet with current graduate students and postdocs.